Synthesis, Characterization, Photophysical and Electrochemical Properties of Pyridine Based Ruthenium Complexes
Abstract
New pyridine based ruthenium complexes with different substituents were synthesized and characterized by Uv-Visible, fluorescence, FTIR and NMR spectroscopies. The substituents and solvent effects of the synthesized compounds on photoluminescence properties have been investigated. The compounds exhibit solvatochromic effect in different solvents. The electrochemical studies of the compounds were performed by cyclic voltammetry. The HOMO and LUMO energy levels are in the range (-5.51)-(-5.52) eV and (-3.04)-(-3.07) eV, respectively. These results indicate that there is no an important effect of side groups on electrochemical properties.
Keywords
References
- [1] B.-F. Qian, J.-L. Wang, A.-Q. Jia, H.-T. Shi, and Q.-F. Zhang, “Syntheses, reactivity, structures and photocatalytic properties of mononuclear ruthenium(II) complexes supported by 1,4,7-trimethyl-1,4,7-triazacyclononane (Me3tacn) ligands,” Inorganica Chim. Acta, vol. 516, p. 120128, 2021.
- [2] Y. Huang, W.-C. Chen, X.-X. Zhang, R. Ghadari, X.-Q. Fang, T. Yu, and F.-T. Kong, “Ruthenium complexes as sensitizers with phenyl-based bipyridine anchoring ligands for efficient dye-sensitized solar cells,” J. Mater. Chem. C, vol. 6, no. 35, pp. 9445–9452, 2018.
- [3] M. S. Costa, Y. G. Gonçalves, B. C. Borges, M. J. B. Silva, M. K. Amstalden, T. R. Costa, L. M. G. Antunes, R. S. Rodrigues, V. M. Rodrigues, E. F. Franca, M. A. P. Zoia, T. G. Araújo, L. R. Goulart, G. V. Poelhsitz, and K. A. G. Yoneyama, “Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity,” Sci. Rep., vol. 10, no. 1, p. 15410, 2020.
- [4] F. H. Haghighi, H. Hadadzadeh, F. Darabi, H. Farrokhpour, M. Daryanavard, and H. A. Rudbari, “Bis- and tris(2,3-dihydro-4a,12b-(epoxyethanooxy)[1,4]dioxino[2,3-f][1,10]phenanthroline) complexes of Ru(II): Synthesis, structure and DNA binding properties,” J. Mol. Struct., vol. 1040, pp. 98–111, 2013.
- [5] L. Zeng, P. Gupta, Y. Chen, E. Wang, L. Ji, H. Chao, and Z.-S. Chen, “The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials,” Chem. Soc. Rev., vol. 46, no. 19, pp. 5771–5804, 2017.
- [6] A. Lapasam, V. Banothu, U. Addepally, and M. R. Kollipara, “Half-sandwich arene ruthenium, rhodium and iridium thiosemicarbazone complexes: synthesis, characterization and biological evaluation,” J. Chem. Sci., vol. 132, no. 1, p. 34, 2020.
- [7] O. Dömötör and É. A. Enyedy, “Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study,” JBIC J. Biol. Inorg. Chem., vol. 24, no. 5, pp. 703–719, 2019.
- [8] A. Gatti, A. Habtemariam, I. Romero-Canelón, J.-I. Song, B. Heer, G. J. Clarkson, D. Rogolino, P. J. Sadler, and M. Carcelli, “Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity,” Organometallics, vol. 37, no. 6, pp. 891–899, 2018.
- [9] O. A. Lenis-Rojas, A. R. Fernandes, C. Roma-Rodrigues, P. V. Baptista, F. Marques, D. Pérez-Fernández, J. Guerra-Varela, L. Sánchez, D. Vázquez-García, M. López Torres, A. Fernández, and J. J. Fernández, “Heteroleptic mononuclear compounds of ruthenium(II): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos,” Dalt. Trans., vol. 45, pp. 19127–19140, 2016.